Injectable Weight Loss Treatments: Minimizing Injection Site Itching
Understanding the Dermatological Mechanisms Behind Injection Site Itching in Weight Loss Therapy Injectable weight loss treatments such as GLP-1 receptor agonists (e.g., semaglutide and tirzepatide) have transformed obesity management by enhancing metabolic regulation. However, injection site itching remains a frequent dermatological side effect, often attributed to localized immune responses and histamine release. This pruritus is … Read more